image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

NMC Health - Shares closing in on £7 following large acquisition

May 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NMC
  • Price:
  • 675p
In our update last December we suggested “2015 could be NMC’s year” and so it has proved with the shares soaring almost vertically to a high of 675p. The catalyst was the acquisition of 86% of Clinica Eugin, a Barcelona-based fertility treatment provider for Eu123.5m (10.2x EBITDA), triggering significant forecast upgrades.Eugin is one of the largest European providers of fertility treatments by number of cycles performed annually and has the largest egg bank in Europe. It provides c. 10% of donor IVF treatments in Europe, while its range includes intra-uterine insemination, in-vitro fertilisation, fertility preservation and genetic screening. For the year ended December 2014 it generated turnover of Eu34.3m and E ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe